ABCC4 and cancer: Contrasting the known efflux pumps P-gp, MRP1, and MRP2, MRP4 displays a symmetrical molecular framework and recently became an attractive target for cancer therapy because it transports several anticancer drugs not similar to the older known efflux pumps [24,25].